Company

TELA Bio, Inc.

Malvern-based surgical reconstruction company whose OviTex® reinforced tissue matrix repairs soft tissue.

About

Founded in 2012 and headquartered in Malvern, US, TELA Bio, Inc. makes surgical reconstruction products led by OviTex®, a reinforced tissue matrix of ovine rumen interwoven with polymer suture, used in hernia and abdominal wall reconstruction. Antony Koblish is CEO. The company has completed 12 deals and raised USD 32.00 mn in a Private Placement, and it reported revenue of USD 69.30 mn and EBITDA of USD -33.10 mn in 2024.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in